Macrogenics, Inc. rose 7.47% in intraday trading, with the company announcing that its President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. The presentation is expected to provide insights into the company's innovative antibody-based therapeutics for cancer treatment, which may have contributed to the positive market sentiment.
Comments
No comments yet